| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, General Counsel
2 companies
Leung Sandra is an EVP, General Counsel at BRISTOL MYERS SQUIBB CO with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $20.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2022 | BMY Bristol Myers Squibb Co | EVP, General Counsel | Sell | 65,000 | $74.89 | $4,867,850.00 | -17.4% | -8.1% | -11.7% | |
| Jul 30, 2021 | BMY Bristol Myers Squibb Co | EVP, General Counsel | Sell | 29,390 | $68.04 | $1,999,695.60 | -8.0% | -15.1% | +12.1% | |
| Aug 13, 2020 | BMY Bristol Myers Squibb Co | EVP, General Counsel | Sell | 141,420 | $63.24 | $8,943,400.80 | -24.6% | - | - |